Dr Husna Begum was an APPRISE Research Fellow and the central project manager for the SPRINT-SARI (Short PeRiod IncideNce sTudy of Severe Acute Respiratory Infection) study in the clinical research and infection prevention pillar of APPRISE. For this work she was based at the Australian and New Zealand Intensive Care Research Centre at Monash University.
Husna is currently a project manager for the Australian Clinical Trials Alliance.
Husna specialises in operationalising large multicentre clinical research studies. During her time with APPRISE, she worked with the SPRINT-SARI management committee, international intensive care unit (ICU) networks and other pandemic preparedness stakeholders to develop standardised data collection tools and test them globally for various infectious syndromes.
Find out more about SPRINT-SARI at http://www.sprintsari.org
APPRISE Fellowship Project: Implementing sustainable models of surveillance for clinically important syndromes associated with emerging infectious diseases
Project: SPRINT-SARI (Short PeRiod IncideNce sTudy of Severe Acute Respiratory Infection) is an important step forward in achieving preparedness to conduct observational studies of infectious syndromes during future pandemics or regional epidemics
Supervisors: Professor Steve Webb and Professor Allen Cheng
- An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study
- ISARIC-COVID-19 dataset: A prospective, standardized, global dataset of patients hospitalized with COVID-19
- People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in Australia
- Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol
- Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic